You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Merck
Moodys
Johnson and Johnson
Colorcon

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Ciraparantag

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ciraparantag?

Ciraparantag is an investigational drug.

There have been 4 clinical trials for Ciraparantag. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2020.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Perosphere, Inc., Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., and [disabled in preview].

There are four US patents protecting this investigational drug and forty-one international patents.

Recent Clinical Trials for Ciraparantag
TitleSponsorPhase
Study of Ciraparantag for Reversal of Anticoagulation Induced by Apixaban or Rivaroxaban in Healthy AdultsPerosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.Phase 2
Phase 2 Placebo-Controlled, Study of Apixaban Reversal by Ciraparantag as Measured by WBCTPerosphere, Inc.Phase 2
Study of Ciraparantag Administered to Volunteers Anticoagulated With Rivaroxaban, Measure Clotting Times Using WBCTPerosphere, Inc.Phase 2

See all Ciraparantag clinical trials

Clinical Trial Summary for Ciraparantag

Top disease conditions for Ciraparantag
Top clinical trial sponsors for Ciraparantag

See all Ciraparantag clinical trials

US Patents for Ciraparantag

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ciraparantag   Start Trial Anticoagulant reversal agents PEROSPHERE INC. (Danbury, CT)   Start Trial
Ciraparantag   Start Trial Anticoagulant reversal agents PEROSPHERE INC. (Danbury, CT)   Start Trial
Ciraparantag   Start Trial Stable glucagon formulations Perosphere Inc. (Danbury, CT)   Start Trial
Ciraparantag   Start Trial Labeled compounds and methods of imaging, diagnosing cartilage disorders and diseases, and monitoring cartilage health using labeled and unlabeled compounds PEROSPHERE PHARMACEUTICALS INC. (Danbury, CT)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ciraparantag

Drugname Country Document Number Estimated Expiration Related US Patent
Ciraparantag Argentina AR089020 2031-11-29   Start Trial
Ciraparantag Australia AU2012345975 2031-11-29   Start Trial
Ciraparantag Brazil BR112014012892 2031-11-29   Start Trial
Ciraparantag Canada CA2856540 2031-11-29   Start Trial
Ciraparantag Chile CL2014001399 2031-11-29   Start Trial
Ciraparantag China CN104080772 2031-11-29   Start Trial
Ciraparantag Colombia CO6990738 2031-11-29   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Merck
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.